A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies

Clinical trial NCT07621146 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07621146
Sponsor: British Columbia Cancer Agency
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Neuroendocrine Tumors, NET Pheochromocytoma/Paraganglioma SSTR-expressing Tumors Medullary Thyroid Carcinoma

Start date: 2026-09-15
Primary completion: 2027-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.